name:  [known lastname 17394],[known firstname ] / sister            unit [name (ni) ]:   [numeric identifier 17395]admission date:  [2111-1-17]              discharge date:   [2111-1-27]date of birth:  [2030-2-21]             sex:   fservice: medicineallergies:sulfa (sulfonamides)attending:[first name3 (lf) 1513]addendum:re: medication changes made prior to dischargebrief hospital course:# a.fib-  here digoxin level continued to trend down.  ondischarge, digoxin level was 1.3 however we elected not torestart given her recent toxicity and development ofnausea/retching.  for now we will continue with beta blocker forrate control.  the metoprolol will be swicthed to toprol xl.# chf- added imdur 30mg qday given bp's still in the 140-160range.  also will change metoprolol 50mg tid to toprol xl 150mgqday.# [name (ni) 16357] pt has been on lipitor prior to admission.  her ast/altwere mildy elevated at 50/56.  these should be recheck as anoutpatient.  for now continued her lipitor.discharge medications:1. atorvastatin calcium 40 mg tablet sig: one (1) tablet podaily (daily).2. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewablepo daily (daily).3. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig:one (1) tablet, delayed release (e.c.) po q24h (every 24 hours).4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2times a day).disp:60 capsule(s) refills:25. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times aday).disp:30 tablet(s) refills:26. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2)tablet, delayed release (e.c.) po daily (daily) as needed.disp:30 tablet, delayed release (e.c.)(s) refills:57. aluminum-magnesium hydroxide 225-200 mg/5 ml suspension sig:15-30 mls po qid (4 times a day) as needed.8. spironolactone 25 mg tablet sig: one (1) tablet po daily(daily).9. lisinopril 20 mg tablet sig: two (2) tablet po daily (daily).10. bumetanide 2 mg tablet sig: two (2) tablet po qam (once aday (in the morning)).11. bumetanide 2 mg tablet sig: one (1) tablet po qpm (once aday (in the evening)).12. zolpidem tartrate 5 mg tablet sig: one (1) tablet po hs (atbedtime) as needed for insomnia.13. imdur 30 mg tablet sustained release 24hr sig: one (1)tablet sustained release 24hr po once a day.disp:30 tablet sustained release 24hr(s) refills:214. toprol xl 50 mg tablet sustained release 24hr sig: three (3)tablet sustained release 24hr po once a day.discharge disposition:extended carefacility:[hospital6 3465] - [location (un) 824]discharge diagnosis:left frontal lobe contusionchfcadhyperlipidemiaa.fibdischarge condition:stable, no sob, ambulating without dyspnea, no neuro deficitsdischarge instructions:please take all medications as instructed. please do not restartyour digoxin and follow up with your doctors regardingcontrolling your heart rate with other medications.do not start taking your coumadin until told to do so by yourdoctors,this should be restarted about [2111-2-8] but check withyour doctors [first name (titles) 17396] [last name (titles) 17397].if you experience any chest pain, shortness of breath, lowerextremity swelling, weight gain, lightheadedness you should seekmedical attention.followup instructions:1.  follow-up with dr. [last name (stitle) ] in [1-11] wks.  call[telephone/fax (1) 8659] for an appointment.  please inform the office thatyou need a head ct scan prior to your appointment.2.  follow-up with your outpatient ophthalmologist in 4 wks.3.  follow-up with your primary care physician [last name (namepattern4) ]. [last name (stitle) ] toevaluate a l thyroid calcification noted on the ct scan.  alsoyou need to follow up with dr. [last name (stitle) ] in regards to your heartfailure and atrial fibrillation.  it has been recommended thatyour coumadin be held for 3 weeks until [2-8].  also need tohave your lfts closely followed given mild elevation and patienton lipitor.4.  you should follow up with your cardiologist about chf anda.fib management.                             [first name11 (name pattern1) ] [last name (namepattern4) 1514] md [md number(2) 1515]completed by:[2111-1-27]